Severe Acute Respiratory Syndrome Coronavirus 2 Infection among Returnees to Japan from Wuhan, China, 2020
In early 2020, Japan repatriated 566 nationals from China. Universal laboratory testing and 14-day monitoring of returnees detected 12 cases of severe acute respiratory syndrome coronavirus 2 infection; initial screening results were negative for 5. Common outcomes were remaining asymptomatic (n = 4) and pneumonia (n = 6). Overall, screening performed poorly..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:26 |
---|---|
Enthalten in: |
Emerging Infectious Diseases - 26(2020), 7, Seite 1596-1600 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Yuzo Arima [VerfasserIn] |
---|
Links: |
doi.org [kostenfrei] |
---|
Themen: |
Asymptomatic infections |
---|
doi: |
10.3201/eid2607.200994 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
DOAJ023746475 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ023746475 | ||
003 | DE-627 | ||
005 | 20230307070330.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230226s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3201/eid2607.200994 |2 doi | |
035 | |a (DE-627)DOAJ023746475 | ||
035 | |a (DE-599)DOAJ6b8f28d6b2be41219a603a00fa859e90 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
050 | 0 | |a RC109-216 | |
100 | 0 | |a Yuzo Arima |e verfasserin |4 aut | |
245 | 1 | 0 | |a Severe Acute Respiratory Syndrome Coronavirus 2 Infection among Returnees to Japan from Wuhan, China, 2020 |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a In early 2020, Japan repatriated 566 nationals from China. Universal laboratory testing and 14-day monitoring of returnees detected 12 cases of severe acute respiratory syndrome coronavirus 2 infection; initial screening results were negative for 5. Common outcomes were remaining asymptomatic (n = 4) and pneumonia (n = 6). Overall, screening performed poorly. | ||
650 | 4 | |a Asymptomatic infections | |
650 | 4 | |a bias | |
650 | 4 | |a pneumonia | |
650 | 4 | |a prevalence | |
650 | 4 | |a quarantine | |
650 | 4 | |a COVID-19 | |
653 | 0 | |a Medicine | |
653 | 0 | |a R | |
653 | 0 | |a Infectious and parasitic diseases | |
700 | 0 | |a Satoshi Kutsuna |e verfasserin |4 aut | |
700 | 0 | |a Tomoe Shimada |e verfasserin |4 aut | |
700 | 0 | |a Motoi Suzuki |e verfasserin |4 aut | |
700 | 0 | |a Tadaki Suzuki |e verfasserin |4 aut | |
700 | 0 | |a Yusuke Kobayashi |e verfasserin |4 aut | |
700 | 0 | |a Yuuki Tsuchihashi |e verfasserin |4 aut | |
700 | 0 | |a Haruna Nakamura |e verfasserin |4 aut | |
700 | 0 | |a Kaoru Matsumoto |e verfasserin |4 aut | |
700 | 0 | |a Asuka Takeda |e verfasserin |4 aut | |
700 | 0 | |a Keisuke Kadokura |e verfasserin |4 aut | |
700 | 0 | |a Tetsuro Sato |e verfasserin |4 aut | |
700 | 0 | |a Yuichiro Yahata |e verfasserin |4 aut | |
700 | 0 | |a Noriko Nakajima |e verfasserin |4 aut | |
700 | 0 | |a Minoru Tobiume |e verfasserin |4 aut | |
700 | 0 | |a Ikuyo Takayama |e verfasserin |4 aut | |
700 | 0 | |a Tsutomu Kageyama |e verfasserin |4 aut | |
700 | 0 | |a Shinji Saito |e verfasserin |4 aut | |
700 | 0 | |a Naganori Nao |e verfasserin |4 aut | |
700 | 0 | |a Tamano Matsui |e verfasserin |4 aut | |
700 | 0 | |a Tomimasa Sunagawa |e verfasserin |4 aut | |
700 | 0 | |a Hideki Hasegawa |e verfasserin |4 aut | |
700 | 0 | |a Kayoko Hayakawa |e verfasserin |4 aut | |
700 | 0 | |a Shinya Tsuzuki |e verfasserin |4 aut | |
700 | 0 | |a Yusuke Asai |e verfasserin |4 aut | |
700 | 0 | |a Tetsuya Suzuki |e verfasserin |4 aut | |
700 | 0 | |a Satoshi Ide |e verfasserin |4 aut | |
700 | 0 | |a Keiji Nakamura |e verfasserin |4 aut | |
700 | 0 | |a Yuki Moriyama |e verfasserin |4 aut | |
700 | 0 | |a Noriko Kinoshita |e verfasserin |4 aut | |
700 | 0 | |a Yutaro Akiyama |e verfasserin |4 aut | |
700 | 0 | |a Yusuke Miyazato |e verfasserin |4 aut | |
700 | 0 | |a Hidetoshi Nomoto |e verfasserin |4 aut | |
700 | 0 | |a Takato Nakamoto |e verfasserin |4 aut | |
700 | 0 | |a Masayuki Ota |e verfasserin |4 aut | |
700 | 0 | |a Sho Saito |e verfasserin |4 aut | |
700 | 0 | |a Masahiro Ishikane |e verfasserin |4 aut | |
700 | 0 | |a Shinichiro Morioka |e verfasserin |4 aut | |
700 | 0 | |a Kei Yamamoto |e verfasserin |4 aut | |
700 | 0 | |a Mugen Ujiie |e verfasserin |4 aut | |
700 | 0 | |a Mari Terada |e verfasserin |4 aut | |
700 | 0 | |a Haruhito Sugiyama |e verfasserin |4 aut | |
700 | 0 | |a Norihiro Kokudo |e verfasserin |4 aut | |
700 | 0 | |a Norio Ohmagari |e verfasserin |4 aut | |
700 | 0 | |a Makoto Ohnishi |e verfasserin |4 aut | |
700 | 0 | |a Takaji Wakita |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t Emerging Infectious Diseases |d Centers for Disease Control and Prevention, 2003 |g 26(2020), 7, Seite 1596-1600 |w (DE-627)DOAJ000014966 |x 10806059 |7 nnns |
773 | 1 | 8 | |g volume:26 |g year:2020 |g number:7 |g pages:1596-1600 |
856 | 4 | 0 | |u https://doi.org/10.3201/eid2607.200994 |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/6b8f28d6b2be41219a603a00fa859e90 |z kostenfrei |
856 | 4 | 0 | |u https://wwwnc.cdc.gov/eid/article/26/7/20-0994_article |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/1080-6040 |y Journal toc |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/1080-6059 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_DOAJ | ||
951 | |a AR | ||
952 | |d 26 |j 2020 |e 7 |h 1596-1600 |